Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) was the recipient of some unusual options trading on Friday. Investors purchased 13,474 put options on the company. This represents an increase of approximately 486% compared to the average daily volume of 2,299 put options. Analyst Upgrades and Downgrades A number of analysts recently issued reports […]
By Denny Jacob Anavex Life Sciences shares rose 9.4% to $6.86 following an initiated process for submitting an application to European regulators regarding.
Nwam LLC raised its position in Anavex Life Sciences Corp. (NASDAQ:AVXL – Free Report) by 15.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 634,600 shares of the biotechnology company’s stock after purchasing an additional 86,363 shares during the […]
Anavex Life Sciences (NASDAQ:AVXL – Get Free Report) and Alvotech (NYSE:ALVO – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, earnings, dividends, profitability and risk. Valuation & Earnings This table compares Anavex Life […]
Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL – Get Free Report) reached a new 52-week low during trading on Monday . The company traded as low as $6.49 and last traded at $6.51, with a volume of 122815 shares. The stock had previously closed at $6.55. Analysts Set New Price Targets AVXL has been the […]